Related Experiment Video
Updated: Jan 26, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
Liver Abscess in a Pediatric Patient with Ulcerative Colitis: A Case Presentation
Daniel F Castillo1, Ricardo Caicedo2, Vani Gopalareddy2
1Department of Pediatrics, Atrium Health- Levine Children's Hospital, Charlotte, NC, USA.
This study reports the first pediatric case of hepatic abscesses and portal vein thrombosis in a patient with ulcerative colitis (UC). The findings highlight a rare but serious complication of inflammatory bowel disease in children.
Area of Science:
- Gastroenterology
- Hepatology
- Pediatrics
Background:
- Hepatic abscesses are rare extra-intestinal manifestations of inflammatory bowel disease (IBD).
- The risk stratification for hepatic abscesses in Crohn's disease versus ulcerative colitis (UC) remains debated.
- Hepatic abscesses in pediatric patients with UC are exceptionally rare, with no prior reported cases.
Observation:
- This report details a pediatric patient diagnosed with UC who subsequently developed hepatic abscesses and portal vein thrombosis.
- The patient experienced an extended period of UC remission without immunosuppressive therapy.
- The clinical course and therapeutic interventions are analyzed for potential contributions to the observed complications.
Findings:
- The case presents the first documented instance of hepatic abscesses and portal vein thrombosis in a pediatric patient with UC.
- This occurrence challenges the existing understanding of UC as a risk factor for hepatic abscesses in pediatric populations.
- The patient's prolonged remission and treatment modifications offer unique insights into disease management and complication development.
Implications:
- This case underscores the importance of considering hepatic abscesses as a potential complication in pediatric IBD, particularly UC.
- Further research is warranted to elucidate the specific risk factors and mechanisms linking UC to hepatic abscesses in children.
- Clinical management strategies for pediatric IBD may need re-evaluation to address the risk of such rare but severe complications.
More Related Videos
15:49Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Ulcerative Colitis in IBD
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption